TREATMENTS FOR CERVICAL CANCER: PRESENT DIFFICULTIES AND PROSPECTS

Almost 300,000 women die from cervical cancer each year, making it the fourth most frequent cancer in the world among women.The human papillomavirus high-risk subtypes that cause cervical cancer are the primary cause of the disease.Together with host factors, the E5, E6, and E7 viral proto-oncogene start and maintain the maligant phenotype.In low-and middleincome nations, however, the disease is fatal for women because of their limited resources, which frequently result in advanced and incurable sickness.Radiation therapy, chemotherapy, and/or surgery are available as treatments, either separately or in combination.This review outlines the causes and symptoms of cervical cancer and goes into detail about the benefits and drawbacks of the current cervical cancer therapies.The future of cervical cancer treatment is then covered, including immunotherapies, targeted medicines, combination therapies, and genetic treatment options. KEY FACTS:According to estimates, cervical cancer will account for 350 000 deaths and 660 000 new cases in 2022, making it the fourth most frequent malignancy among women globally.• Low-and middle-income countries see higher rates of cervical cancer incidence and